Article

Dr. Boyer joins iCo strategic advisory board

Vancouver, British Columbia-iCo Therapeutics Inc. announced that David S. Boyer, MD, will join its strategic advisory team.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.